Skip to main content
Erschienen in: Clinical Rheumatology 4/2007

01.04.2007 | Original Article

Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study

verfasst von: Aşkin Ateş, Gülay Kinikli, Murat Turgay, Gülay Akay, Güner Tokgöz

Erschienen in: Clinical Rheumatology | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

The value of rheumatoid factor (RF) isotypes for assessing rheumatoid arthritis (RA) remains debatable. In this study, we have examined the relationships between RF isotypes and disease activity and severity in RA patients. Sixty-two patients with RA, 48 women and 14 men, were studied. RF was measured by nephelometry (RF–N) and IgG–, IgA–, and IgM–RF isotypes were measured using enzyme-linked immunosorbent assay. Serum C-reactive protein and erythrocyte sedimentation rate were also determined. The patients were classified according to disease activity, joint damage, functional status, and presence of pulmonary involvement, rheumatoid nodule, and secondary Sjögren’s syndrome. Although the patients with active disease had significantly higher IgA–RF and IgM–RF levels compared to inactive patients, IgA–RF and IgM–RF were not found to be independently associated with disease activity in multivariate analysis. In patients with severe joint damage, IgA–RF and RF–N were significantly higher than those of the other patients. Multiple regression analysis showed that IgA–RF was the unique variable independently associated to severe joint damage. The patients with class III and IV functional index had significantly higher IgM–RF, IgA–RF, and RF–N levels compared to the patients with class I and II functional index; however, RFs were not significantly associated with functional status in multivariate analysis. IgA–RF and IgM–RF were significantly associated with pulmonary involvement and rheumatoid nodule, respectively. No significant associations were found between RF isotypes and secondary Sjögren’s syndrome. Our results suggest that the clinical usefulness of IgA and IgM isotypes is better than RF–N. Elevated IgA–RF may be a marker of erosive disease. The usefulness of RF isotypes for monitoring disease activity or functional status appears to be limited.
Literatur
1.
Zurück zum Zitat Bartfeld H (1969) Distribution of rheumatoid factor activity in nonrheumatoid states. Ann NY Acad Sci 168:30–40PubMedCrossRef Bartfeld H (1969) Distribution of rheumatoid factor activity in nonrheumatoid states. Ann NY Acad Sci 168:30–40PubMedCrossRef
2.
Zurück zum Zitat Silvestris F, Anderson W, Goodwin JS, Williams RC Jr (1985) Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 35:234–244PubMedCrossRef Silvestris F, Anderson W, Goodwin JS, Williams RC Jr (1985) Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 35:234–244PubMedCrossRef
3.
Zurück zum Zitat Van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, Van’t Hof MA, van Rijswijk MH, van de Putte LBA (1992) Prognostic factors for radiologic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 31:519–525PubMedCrossRef Van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, Van’t Hof MA, van Rijswijk MH, van de Putte LBA (1992) Prognostic factors for radiologic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 31:519–525PubMedCrossRef
4.
Zurück zum Zitat Möttenen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P (1998) Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with ‘sawtooth’ strategy. Ann Rheum Dis 57:533–539CrossRef Möttenen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P (1998) Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with ‘sawtooth’ strategy. Ann Rheum Dis 57:533–539CrossRef
5.
Zurück zum Zitat Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X (2003) Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 42:939–946PubMedCrossRef Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X (2003) Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 42:939–946PubMedCrossRef
6.
Zurück zum Zitat Tarkowski A, Nilsson LA (1983) Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol 12:129–135PubMed Tarkowski A, Nilsson LA (1983) Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol 12:129–135PubMed
7.
Zurück zum Zitat Möttönen T, Hannonen P, Jokinen I, Arvilommi M, Oka M (1988) Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent onset rheumatoid arthritis. Scand J Rheumatol 75(Suppl):244–249 Möttönen T, Hannonen P, Jokinen I, Arvilommi M, Oka M (1988) Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent onset rheumatoid arthritis. Scand J Rheumatol 75(Suppl):244–249
8.
Zurück zum Zitat Jonsson T, Thorsteinsson J, Kolbeinsson A, Jonasdottir E, Sigfusson N, Valdimarsson H (1992) Population study of the importance of rheumatoid factor isotypes in adult. Ann Rheum Dis 51:863–868PubMed Jonsson T, Thorsteinsson J, Kolbeinsson A, Jonasdottir E, Sigfusson N, Valdimarsson H (1992) Population study of the importance of rheumatoid factor isotypes in adult. Ann Rheum Dis 51:863–868PubMed
9.
Zurück zum Zitat van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC (1992) Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 51:1029–1035PubMed van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC (1992) Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 51:1029–1035PubMed
10.
Zurück zum Zitat van Leeuwen MA, Westra J, van Riel PLCM, Limburg PC, van Rijswijk MH (1995) IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 24:146–153PubMed van Leeuwen MA, Westra J, van Riel PLCM, Limburg PC, van Rijswijk MH (1995) IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 24:146–153PubMed
11.
Zurück zum Zitat Houssien DA, Jonsson T, Davies E, Scott DL (1998) Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis. Comparative effects of different antigens. Scand J Rheumatol 27:46–53PubMedCrossRef Houssien DA, Jonsson T, Davies E, Scott DL (1998) Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis. Comparative effects of different antigens. Scand J Rheumatol 27:46–53PubMedCrossRef
12.
Zurück zum Zitat Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677–680PubMedCrossRef Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677–680PubMedCrossRef
13.
Zurück zum Zitat Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427–430PubMedCrossRef Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427–430PubMedCrossRef
14.
Zurück zum Zitat Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC (1987) IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 46:65–71PubMed Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC (1987) IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 46:65–71PubMed
15.
Zurück zum Zitat Eberhardt KB, Svensson B, Truedsson L, Wollheim FA (1988) The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis—no relationship with erosions or disease activity. J Rheumatol 15:1070–1074PubMed Eberhardt KB, Svensson B, Truedsson L, Wollheim FA (1988) The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis—no relationship with erosions or disease activity. J Rheumatol 15:1070–1074PubMed
16.
Zurück zum Zitat McDougal JS, Hubbard M, McDuffie FC, Strobel PL, Smith SJ, Bass N, Goldman JA, Hartman S, Myerson G, Miller S, Morales R, Wilson CH Jr (1982) Comparison of five assays for immune complexes in the rheumatic diseases. An assessment of their validity in rheumatoid arthritis. Arthritis Rheum 25:1156–1166PubMedCrossRef McDougal JS, Hubbard M, McDuffie FC, Strobel PL, Smith SJ, Bass N, Goldman JA, Hartman S, Myerson G, Miller S, Morales R, Wilson CH Jr (1982) Comparison of five assays for immune complexes in the rheumatic diseases. An assessment of their validity in rheumatoid arthritis. Arthritis Rheum 25:1156–1166PubMedCrossRef
17.
Zurück zum Zitat Withrington RH, Teitsson I, Valdimarsson H, Seifert MH (1984) Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann Rheum Dis 43:679–685PubMed Withrington RH, Teitsson I, Valdimarsson H, Seifert MH (1984) Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann Rheum Dis 43:679–685PubMed
18.
Zurück zum Zitat Highton J, Hessian PA, Small B, Palmer DG (1985) An assessment of the diagnostic value of quantitative measurements of IgA rheumatoid factor. J Rheumatol 12:854–858PubMed Highton J, Hessian PA, Small B, Palmer DG (1985) An assessment of the diagnostic value of quantitative measurements of IgA rheumatoid factor. J Rheumatol 12:854–858PubMed
19.
Zurück zum Zitat Westedt ML, Herbrink P, Molenaar JL, de Vries E, Verlaan P, Stijnen T, Cats A, Lindeman J (1985) Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int 5:209–214PubMedCrossRef Westedt ML, Herbrink P, Molenaar JL, de Vries E, Verlaan P, Stijnen T, Cats A, Lindeman J (1985) Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int 5:209–214PubMedCrossRef
20.
Zurück zum Zitat March RE, Kirwan JR, Reeback JS, Holborow EJ (1987) IgM, IgG and IgA rheumatoid factors (antiglobulins) in early rheumatoid arthritis and their production of articular index over one year. Scand J Rheumatol 16:407–411PubMedCrossRef March RE, Kirwan JR, Reeback JS, Holborow EJ (1987) IgM, IgG and IgA rheumatoid factors (antiglobulins) in early rheumatoid arthritis and their production of articular index over one year. Scand J Rheumatol 16:407–411PubMedCrossRef
21.
Zurück zum Zitat Carpenter AB, Smailer S (1989) Measurement of rheumatoid factor isotypes in the clinical laboratory. Immunol Invest 18:765–773PubMed Carpenter AB, Smailer S (1989) Measurement of rheumatoid factor isotypes in the clinical laboratory. Immunol Invest 18:765–773PubMed
22.
Zurück zum Zitat Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Yamada Y, Toumatu J (1998) Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren’s syndrome and rheumatoid arthritis. Clin Exp Rheumatol 16:709–715PubMed Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Yamada Y, Toumatu J (1998) Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren’s syndrome and rheumatoid arthritis. Clin Exp Rheumatol 16:709–715PubMed
23.
Zurück zum Zitat Luthviksson BR, Jonsson T, Erlendsson K, Sigfusson A (1992) Disease manifestations in patients with isolated elevation of IgA rheumatoid factor. Scand J Rheumatol 21:1–4PubMed Luthviksson BR, Jonsson T, Erlendsson K, Sigfusson A (1992) Disease manifestations in patients with isolated elevation of IgA rheumatoid factor. Scand J Rheumatol 21:1–4PubMed
24.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
25.
Zurück zum Zitat Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308–1315PubMedCrossRef Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308–1315PubMedCrossRef
26.
Zurück zum Zitat Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 8:481–491 Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 8:481–491
27.
Zurück zum Zitat Hochberg MC, Chang RW, Dwash I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502PubMed Hochberg MC, Chang RW, Dwash I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502PubMed
28.
Zurück zum Zitat Jonsson T, Valdimarsson H (1992) Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Rheumatol Int 12:111–113PubMedCrossRef Jonsson T, Valdimarsson H (1992) Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Rheumatol Int 12:111–113PubMedCrossRef
29.
Zurück zum Zitat Jonsson T, Valdimarsson H (1993) Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 52:161–164PubMedCrossRef Jonsson T, Valdimarsson H (1993) Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 52:161–164PubMedCrossRef
Metadaten
Titel
Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study
verfasst von
Aşkin Ateş
Gülay Kinikli
Murat Turgay
Gülay Akay
Güner Tokgöz
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 4/2007
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0343-x

Weitere Artikel der Ausgabe 4/2007

Clinical Rheumatology 4/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.